p110beta PI3K-D931A-LacZ
Invented by Bart Vanhaesebroeck
Invented at Ludwig Institute for Cancer Research , The University of Edinburgh
- Datasheet
- References (0)
- Inventor Info
Info
| Catalogue Number | 158391 |
| Antigen/Gene or Protein Targets | PIK3CB |
| Model | Knock-In |
| Production Details | An IRES-lacZ-MC1-neo marker/selection cassette, flanked by loxP sites, was inserted after the STOP codon in the last exon (24) of p110beta PI3K / Knock-in with lacZ casette |
| Breeding Information | Backcrossed onto C57B6/J for more than 10 generations. |
| Research Area | Cancer |
| Notes | Have not been characterised in detail as homo- or heterozygous - express lacZ under the control of the p110beta PI3K promotor. |
References
There are 0 reference entries for this reagent.
References: 0 entry
There is no reference for this reagent yet, feel free to use the button below to suggest one.
Add a reference
References: 0 entry
There is no reference for this reagent yet, feel free to use the button below to suggest one.
Add a reference
Inventor Information
Inventors
|
Bart Vanhaesebroeck |
